Skip to main content

Table 4 Relative intensity of three peptides in AML different groups and healthy control group

From: Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Mass

Ave1 ± StdDev1

Ave2 ± StdDev2

Ave3 ± StdDev3

Ave4 ± StdDev4

n1

n2

n3

n4

3216.57

2.87 ± 1.45

1.83 ± 0.53

1.76 ± 0.48

3.08 ± 1.58

72

72

37

30

4089.7

2.69 ± 1.39

10.08 ± 4.03

11.63 ± 4.51

2.51 ± 1.35

    

7762.87

1.94 ± 1.25

8.36 ± 3.35

8.62 ± 3.55

1.73 ± 1.18

    
  1. Mass mass to charge ratio value, Ave average peak intensity, StdDev standard deviation of the peak intensity, n number of patients, 1 AML newly diagnosed group, 2 healthy control group, 3 AML CR group, 4 AML refractory & relapsed group.
Back to article page

Proteome Science

ISSN: 1477-5956